Zidovudine and Weight abnormal - a phase IV clinical study of FDA data

Summary:

Weight abnormal is reported as a side effect among people who take Zidovudine (zidovudine), especially for people who are female, 0-1 old, also take Nevirapine, and have Hiv infection.

The phase IV clinical study analyzes which people have Weight abnormal when taking Zidovudine. It is created by eHealthMe based on reports of 10,506 people who have side effects when taking Zidovudine from the FDA, and is updated regularly.

What is Zidovudine?

Zidovudine has active ingredients of zidovudine. eHealthMe is studying from 10,517 Zidovudine users. Check the latest studies of Zidovudine.

What is Weight abnormal?

Weight abnormal is found to be associated with 1,619 drugs and 1,299 conditions by eHealthMe. Check the latest studies of Weight abnormal.



On Jul, 19, 2026

10,506 people reported to have side effects when taking Zidovudine.
Among them, 19 people (0.18%) have Weight abnormal.

Could Zidovudine cause Weight abnormal?

Among these 19 people:

What is the gender of people who have Weight abnormal when taking Zidovudine? *

  • female: 82.35 %
  • male: 17.65 %

What is the age of people who have Weight abnormal when taking Zidovudine? *

  • 0-1: 66.67 %
  • 2-9: 22.22 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 11.11 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Zidovudine? *

  1. Folic Acid: 10 people, 52.63%
  2. Nevirapine: 10 people, 52.63%
  3. Didanosine: 9 people, 47.37%
  4. Retrovir: 8 people, 42.11%
  5. Norvir: 8 people, 42.11%
  6. Ergocalciferol: 4 people, 21.05%
  7. Lamivudine: 3 people, 15.79%
  8. Efavirenz: 2 people, 10.53%
  9. Sustiva: 2 people, 10.53%
  10. Stavudine: 2 people, 10.53%

What are other side effects people have besides Weight abnormal? *

  1. High Blood Cholesterol: 15 people, 78.95%
  2. Blood Lactic Acid Increased: 14 people, 73.68%
  3. Hypertriglyceridaemia (excess of triglycerides in the blood): 12 people, 63.16%
  4. Hepatomegaly (abnormal enlargement of the liver): 11 people, 57.89%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10 people, 52.63%
  6. Flatulence (flatus expelled through the anus): 10 people, 52.63%
  7. Blood Creatine Phosphokinase Increased: 9 people, 47.37%
  8. Platelet Count Increased: 9 people, 47.37%
  9. Malaise (a feeling of general discomfort or uneasiness): 9 people, 47.37%
  10. Abdominal Distension: 8 people, 42.11%

What are the existing conditions these people have? *

  1. Hiv Infection: 5 people, 26.32%
  2. Drug Exposure During Pregnancy: 3 people, 15.79%
  3. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Zidovudine and have Weight abnormal?

- Check whether Weight abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zidovudine:

Weight abnormal treatments and more:

How severe was Weight abnormal and when was it recovered:

Expand to all the drugs that have ingredients of zidovudine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zidovudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight abnormal:

Browse all the conditions that are associated with Weight abnormal:


How the study uses the data?

The study uses data from the FDA. It is based on zidovudine (the active ingredients of Zidovudine) and Zidovudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: